# The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus

> **NCT03338205** · PHASE3 · WITHDRAWN · sponsor: **Augusta University**

## Conditions studied

- Status Asthmaticus

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT03338205
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to enroll patients
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03338205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03338205, "The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03338205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*